Incidence of Infusion-Associated Reactions with Rituximab for Treating Multiple Sclerosis: A Retrospective Analysis of Patients Treated at a US Centre

Author： Brown Brandon A.   Torabi Mina  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.34, Iss.2, 2011-02, pp. : 117-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibodies against CD20 (rituximab) for treating multiple sclerosis: US20100233121

By Taupin Philippe  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 1, 2011-01 ,pp. : 111-114

Informa Healthcare

Access to resources Recommend Favorite

Alglucosidase α: Infusion-associated reactions in infants: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1203, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Galsulfase: Infusion-associated reactions (first report) in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1200, 2008-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Treating pain in multiple sclerosis

By Truini Andrea   Galeotti Francesca   Cruccu Giorgio  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2355-2368

Informa Healthcare

Access to resources Recommend Favorite

Rituximab: Infusion reaction treated with plasmapheresis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1251, 2009-01 ,pp. : 30-31

Adis International

Access to resources Recommend Favorite